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Problem Identification
• Prostate cancer accounts for 26% of new cancer cases in US men.1
• Current guidelines established by the U.S. Preventative Services Task Force (USPSTF) for 
men age 55 to 69 years old state that the decision to be screened for prostate cancer 
should be an individual one (Grade C). 2
• For men 70 and older the USPSTF recommends against PSA based screening (Grade D). 2
• Evidence that patient decision aids can improve patient knowledge, and reduce decisional 
conflict. 3
• These findings are weak, can a different modality of information representation aid in improving this 
information exchange?
Public Health Cost
• Estimated 3 year cost to Medicare associated with annual detection of prostate cancer in 
men 70 or older is $1.2 billion.4
• Typical cost of therapy to prostate cancer patient after diagnosis is about $2,800 per 
month. 5
• In Clinton County: 6
• Average Annual Cases = 49.6; Rate per 100k = 92.0
• Average Annual Deaths = 7.8; Rate Per 100k = 17.5
• Nationally:
• Rate of 111.3 per 100,000 men per year. The death rate was 19.0 per 100,000 men7
Clinician Perspectives
• Perspectives obtained from Drs. ___, ___ and ___ of CVPH Family medicine. 
• All endorsed the importance of explaining risks and benefits of any screening test to patients but 
acknowledged that these statistics can be abstract and hard for patients into interpret meaningfully. 
• Dr. ___ suggested that a graphical aid may be helpful in increasing patient comprehension of risks and benefits. 
• Dr. ___ agreed that a graphical representation would be not only beneficial for patient’s but also providers and something he 
would like to incorporate into his practice.
• Currently none of these providers use a decision making aid, graphical or otherwise in their conversations 
about PSA screening.
Intervention
• Patient decision making aids can improve patient’s knowledge and participation in decision 
making and increase  patient confidence in their decisions. 8 
• The goal is to incorporate a graphic patient decision making aid to help patients and 
providers grasp the statistics in a more concrete way when engaging in shared decision 
making around prostate cancer screening.
• Implementation: Graphic can be printed out and brought into patient visits in which PSA 
screening is expected to be discussed. 
• Alternatively could be incorporated as a dot phrase which can be drawn up and displayed during 
patient encounters and included in AVS for patient’s reference.
Results
• USPSTF produces a graphical decision-making aid based on their 2018 PSA 
screening guidelines.
• Received positive feedback from clinic providers and staff as to its ease of use and 
potential benefit. 
• Graphic can be printed out and brought into patient visits in which PSA screening is 
expected to be discussed. 
Evaluation of Effectiveness and Limitations
• Decision about screening is ultimately the patient decision, our role is to help 
maximize their understanding of the risks and benefits. Thus effectiveness would 
be best measured as improvement in patient comprehension.
• A simple Likert scale styled questionnaire could be provided after visit to assess usefulness 
of graphic in comprehension.
• Limitations include language and literacy barriers, vision problems impairing ability 
to interpret graphic.
Recommendations for the Future
• Future projects could examine the utility of this graphic both for the patient 
and provider and identify + implement changes that might prove to be 
beneficial.
• Ensure that data contained within the graphic is up to date with current 
research.
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